TIL therapy broadens the tumor-reactive CD8(+) T cell compartment in melanoma patients

P. Kvistborg, C.J. Shu, B. Heemskerk, M. Fankhauser, C.A. Thrue, M. Toebes, N. van Rooij, C. Linnemann, M.M. Van Buuren, J.H. Urbanus, J.B. Beltman, P.L.Y.F. Thor Straten, P.F. Robbins, M.J. Besser, J. Schachter, G.G. Kenter, M.E. Dudley, S.A. Rosenberg, J.B. Haanen, S.R. HadrupTN Schumacher

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)409-418
JournalOncoImmunology
Volume1
Issue number4
DOIs
Publication statusPublished - 2012

Cite this

Kvistborg, P., Shu, C. J., Heemskerk, B., Fankhauser, M., Thrue, C. A., Toebes, M., ... Schumacher, TN. (2012). TIL therapy broadens the tumor-reactive CD8(+) T cell compartment in melanoma patients. OncoImmunology, 1(4), 409-418. https://doi.org/10.4161/onci.18851